(Q28282822)

https://api.crossref.org/works/10.1517/14728222.9.6.1165

Monoclonal antibody FMC7 detects a conformational epitope on the CD20 molecule: evidence from phenotyping after rituxan therapy and transfectant cell analyses

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728222.9.6.1165

A cholesterol-dependent CD20 epitope detected by the FMC7 antibody

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728222.9.6.1165

Genomic aberrations and survival in chronic lymphocytic leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728222.9.6.1165

MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728222.9.6.1165

miR-15 and miR-16 induce apoptosis by targeting BCL2

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728222.9.6.1165

Human CD38: a glycoprotein in search of a function

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728222.9.6.1165

Human CD38: a (r)evolutionary story of enzymes and receptors

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728222.9.6.1165

CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728222.9.6.1165

21 April 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells.

21 April 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

B-cell chronic lymphocytic leukemia: a bird of a different feather

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Simultaneous flow cytometric analysis of surface markers and nuclear Ki-67 antigen in leukemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Proliferating cell nuclear antigen (PCNA) expression in chronic lymphocytic leukemia (CLL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Somatic generation of antibody diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

The mechanism of antigen receptor gene assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Chronic lymphocytic leukemia: revelations from the B-cell receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Upregulation of CD38 gene expression in leukemic B cells by interferon types I and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Identification of a novel isoform of ZAP-70, truncated ZAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Regulation of B cell fates by BCR signaling components

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Unexpected requirement for ZAP-70 in pre-B cell development and allelic exclusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

B cell development pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

ZAP-70 is expressed by a subset of normal human B-lymphocytes displaying an activated phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Differential intrinsic enzymatic activity of Syk and Zap-70 protein-tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Synthesis and biological activities of novel 17-aminogeldanamycin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

ZAP-70 expression in B-cell hematologic malignancy is not limited to CLL/SLL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

ZAP-70 expression and prognosis in chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

A clinical staging system for chronic lymphocytic leukemia: prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

Diagnostic criteria for monoclonal B-cell lymphocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

The heat shock protein 90-binding geldanamycin inhibits cancer cell proliferation, down-regulates oncoproteins, and inhibits epidermal growth factor-induced invasion in thyroid cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

17-Allylamino-17-demethoxygeldanamycin activity against thyroid cancer cell lines correlates with heat shock protein 90 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165

The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.6.1165